The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Plavix was produced by Sanofi and Bristol-Myers Squibb.
superiority to Sanofi's Plavix (clopidogrel), a former blockbuster now subject to generic competition.
into a market formerly dominated by Sanofi's Plavix (clopidogrel) which lost patent protection in 2012. ... In a trial that compared Kengreal to Plavix in more than 10, 000 participants, TMC's significantly reduced the occurrence of heart attack, the
Sanofi has a number of CV medicines including Aprovel (irbesartan), Lovenox (enoxaparin) and the co-marketed Plavix (clopidogrel), which collectively made the firm 4.2bn euro ($4.7bn) last year, helping
Claims it offers a small benefit over Sanofi’s Plavix. The Medicines Company (TMC) looks on course finally to get approval for its intravenous antiplatelet drug cangrelor in the US after ... the multibillion-dollar market formerly occupied by Sanofi's
Brilinta was first launched in 2011 as potential successor to Sanofi's formerly $7bn-a-year antiplatelet brand Plavix (clopidogrel), which saw its sales decimated by generic competition after key patents
No results were found
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....